MLN0128: Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients

AS1517499 : STAT6 blockade ameliorates thyroid function in Graves’ disease via downregulation of the sodium/iodide symporter

BMS-986165: Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors